论文部分内容阅读
临床上使用粒细胞集落刺激因子（G-CSF）10－200μg（m2·d）作为各种血液病和肿瘤疾病感染的辅助治疗，并认为它比粒一巨噬细胞集落刺激因子（GM－CSF）安全。GM－CSF引起正常组织损害的原因是中性粒细胞的毒性作用增加所致。已有报道thCSF对再生障碍性贫血（AA）的治疗有效，
Clinically, granulocyte colony-stimulating factor (G-CSF) 10-200 μg (m2·d) is used as an adjunctive treatment for various hematological and neoplastic diseases, and it is considered to be more than granulocyte-macrophage colony-stimulating factor (GM-CSF). )Safety. The cause of normal tissue damage caused by GM-CSF is an increase in the toxic effects of neutrophils. ThCSF has been reported to be effective in the treatment of aplastic anemia (AA).